Rescuing Data Integrity: Catalyst's Swift Transition And Quality Transformation

A biotech sponsor confronted ongoing challenges with its study’s data oversight, prompting a transition of key responsibilities to a new partner capable of stabilizing operations and improving data reliability. The transition required rapid coordination among stakeholders to transfer systems, establish administrative controls, and assess the condition of the study database.
Early evaluations revealed critical gaps in programmed safeguards and routine review processes, highlighting the need for immediate corrective action. Through targeted technical updates, structured review procedures, and consistent communication, the new team strengthened data oversight and restored confidence in the study’s operational foundation.
Uncover how continued collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.